Volume 30, Issue 186 (7-2020)
J Mazandaran Univ Med Sci 2020, 30(186): 156-162 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Eslami G, Abedi S, Emami S. Clinical Evaluation of Enoxaparin Prescription in
Mazandaran Heart Center. J Mazandaran Univ Med Sci 2020; 30 (186) :156-162
URL: http://jmums.mazums.ac.ir/article-1-12358-en.html
URL: http://jmums.mazums.ac.ir/article-1-12358-en.html
Abstract: (1533 Views)
Background and purpose: Drug utilization evaluation (DUE) is one of the most effective methods to assess the correct administration of drugs. Enoxaparin is one of the most commonly used anticoagulant which is widely used as prophylactic or curative treatment. The aim of this study was to evaluate the rational use of enoxaparin in Mazandaran Heart Center.
Materials and methods: In a retrospective study, demographic and clinical data of 200 patients who had received enoxaparin in 2017 were collected on the basis of American Hospital Formulary Service (AHFS) drug information, UpToDate, and Medscape guidelines.
Results: The mean age of patients was 61.52 ± 13.62 years. The dosing of enoxaparin was according to guidelines in 163 (81.5%) patients and outside the target ranges in 37 (18.5%).
Conclusion: In this study, the administration of enoxaparin for therapeutic or prophylactic purposes was not according to guidelines in about one-fifth of the patients and it is necessary to determine the precise dosage.
Materials and methods: In a retrospective study, demographic and clinical data of 200 patients who had received enoxaparin in 2017 were collected on the basis of American Hospital Formulary Service (AHFS) drug information, UpToDate, and Medscape guidelines.
Results: The mean age of patients was 61.52 ± 13.62 years. The dosing of enoxaparin was according to guidelines in 163 (81.5%) patients and outside the target ranges in 37 (18.5%).
Conclusion: In this study, the administration of enoxaparin for therapeutic or prophylactic purposes was not according to guidelines in about one-fifth of the patients and it is necessary to determine the precise dosage.
Type of Study: Brief Report |
Subject:
Clinical pharmacy
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s). Owned by Mazandaran University of Medical Sciences.
Contact Us
Address: Journal Office, Building No. 2, Mazandaran University of Medical Sciences, Moallem Square, Sari.Tel: +98 (011)34484874 Postal code: 48175-866 E-Mail: jmums@mazums.ac.ir Telefax: +98 (011)33262679
